Vivo Capital — 2018 Investments
5 investments dated 2018 · listed companies and verified rows first · show all
BiotechSan Diego, US
Richard Scott Struthers(Executive Officer, Director)Stephen F. Betz(Executive Officer)YunFei Zhu(Executive Officer)
BoardMahendra Shah(Director)Steve Kaldor(Director)Mason Freeman(Director)
Board seatJack Nielsen· per SEC Form D · $65M raise · filed Feb 2018
Co-investorsForesite Capital
BiotechSan Diego, US
Francois Ferre(Director)Magda Marquet(Director)Jorge Garces(Executive Officer)Greg Hamilton(Executive Officer, Director)Carin Sandvik(Executive Officer)Jeffrey G. Black(Executive Officer)
Board seatYuh-geng Tsay· per SEC Form D · $3M raise · filed Mar 2018
Co-investorsBioBrit
Amyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products.
Advanced ManufacturingBiotechCleantechNew MaterialsEmeryville, US
NICHOLAS KHADDER(Senior Vice President, General Counsel & Secretary)RAFFI ASADORIAN(Chief Financial Officer)Joel Cherry(President, Research & Development)Tamara Tompkins(Executive Vice President, General Counsel)John Melo(President & Chief Executive Officer)Paulo Diniz(Chief Financial Officer)
Board seatFrank Kung· per SEC Form D · $38.1M raise · filed Apr 2018
Co-investorsKleiner PerkinsR7 Partners
Lite Strategy, Inc.
BiotechCrypto & Web3FintechHealthtechSan Diego, US
David M. Urso(Executive Officer)Daniel P. Gold(Executive Officer, Director)Brian G. Drazba(Executive Officer)Mr. File(Chief Executive Officer & Board Member (former CFO))Kevan E. Clemens(Director)Thomas C. Reynolds(Director)
Co-investors3B Future Health FundAisling CapitalGSRNew Enterprise Associates (NEA)
Ossium Health develops cellular therapies and bioengineered products for clinical use, leveraging adult stem cell technologies and advanced cell processing platforms.
BiotechHealthtechMedical DevicesSan Francisco, US
Kevin Caldwell(CEO, Co-Founder & President)inDr. Woods(Chief Science Officer, Co-Founder, EVP, CLIA Laboratory Director)Sebastian Giwa(Director)Erik Woods(Founder)in
BoardWilliam Trenchard(Director)inThomas Cycyota(Director)
Co-investorsHemisphere Ventures LLCManta Ray VenturesXYZ Venture CapitalFemHealth VenturesFirst Round CapitalVillage Global
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.